UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

Stock Information for Revive Therapeutics Ltd

Loading

Please wait while we load your information from QuoteMedia.